Your browser is no longer supported. Please, upgrade your browser.
Settings
XLV Health Care Select Sector SPDR ETF daily Stock Chart
XLV [NYSE]
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week1.23%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month6.43%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter4.76%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio3.46 Perf Half Y11.37%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-0.79%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range55.76 - 76.16 Perf YTD4.90%
Dividend1.11 P/FCF- EPS past 5Y- ROI- 52W High-1.54% Beta-
Dividend %1.48% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low34.48% ATR0.80
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)71.34 Volatility0.68% 1.04%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.55 Prev Close74.84
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume9.87M Price74.99
Recom- SMA203.29% SMA505.08% SMA2008.27% Volume5,441,818 Change0.20%
Jul-22-16 02:04PM  GILD Developing Next Generation HCV Drugs to Remain Competitive
01:28PM  St. Jude Medical Gets Hold Rating from 96% of Analysts
01:16PM  Is Vertex Pharmaceuticals Exposed to Drug Pricing Risks?
01:16PM  How Alexion Plans to Fuel Strensiq Sales
01:14PM  Why Johnson & Johnsons 2Q16 Profits Fell by 11.5%
01:07PM  What Are Lillys 2Q16 Estimates and Expectations for Elanco?
07:29AM  Abbotts 2Q16 Earnings Propelled by Impressive Sales Growth
05:42AM  Summer's top summer sector: Health care
Jul-21-16 02:00PM  3 Healthcare ETFs to Buy as JNJ Beats Q2 Earnings
08:16AM  4 Healthcare Mutual Funds to Buy on Bright Prospects
Jul-20-16 12:04PM  Behind the bull market
10:13AM  Richard Bernstein on Profits Recession and Portfolio Positioning
Jul-19-16 06:20PM  Dow ETF Notches Fresh Closing High As Blue Chip Stocks Take The Reins
02:24PM  Inside Bill Ackmans Current Stance and View of His Holdings
08:58AM  How to Profit From Abbott Labs
Jul-15-16 01:19PM  For this rally to continue, there must be a change in leadership at MarketWatch
10:29AM  Analysts Ratings of St. Jude Medical before 2Q16 Results
04:23AM  Analysts Latest Recommendations for Intuitive Surgical
Jul-14-16 08:41PM  Abbott Laboratories: Analyst Recommendations before 2Q16 Results
11:56AM  Could the Dow Jump Up Another 400 Points by Year-End?
10:04AM  What Do Analysts Recommend for UNH ahead of 2Q16 Earnings?
Jul-13-16 09:07AM  Will June Jobs Report Speed Up the Feds Next Rate Hike?
Jul-12-16 09:06PM  Regenerons Robust Pipeline
08:06PM  How Are Thermo Fishers Commercial Capabilities Driving Its Share Gains?
06:06PM  What Are Varians Key Initiatives for the Particle Therapy Business?
Jul-11-16 11:42AM  GICS Sectors: Investors Err on the Side of Caution
07:03AM  Does the Rebound in Non-Farm Payrolls Favor a Rate Hike?
01:05AM  A Look at Alexions 2016 Guidance
Jul-09-16 07:05AM  Are Stocks Ready To Rocket Higher?
Jul-08-16 04:35PM  Medtronics Heartware Acquisition: Portfolio Impact
Jul-07-16 05:26PM  Humana stock tumbles nearly 10% steepest daily drop in 4 years at MarketWatch
Jul-06-16 11:50AM  The Driverless City
09:23AM  Health Care Stocks Are Quietly Moving Higher
Jul-05-16 03:06PM  Will General Electrics Healthcare Segment Score in 2Q16?
02:00PM  A Look at the Health Care Select Sector SPDR Fund (XLV, JNJ) at Investopedia
07:05AM  The Amsurg-Envision Material Adverse Effect Clause: Part 3
Jul-01-16 01:33PM  Brexit is a result of slow growth forever at MarketWatch
Jun-30-16 10:41AM  Brexit Bounce Still Favors Bearish Outcome (XLF, XLB) at Investopedia
Jun-29-16 04:21PM  Fund Managers Flocked To Energy, Materials in 2Q at Barrons.com
02:06PM  Why Did Alexion Fall after Brexit?
01:56PM  The Amsurg-Envision Material Adverse Effect Clause: Part 2
01:55PM  The Amsurg-Envision Material Adverse Effect Clause: Part 1
07:12AM  Shire's stock surges after ADHD drug trial meets key endpoints at MarketWatch
Jun-28-16 02:55PM  What New Medicines Were Recommended during the CHMPs June Meeting?
01:06PM  Bill Ackman Is Dead Wrong for Shorting Herbalife, Says Carl Icahn
11:16AM  Private Insurance Doesn't Mean Lower Out-Of-Pocket Costs
11:07AM  Inside AbbVies Analyst Recommendations in 2016
Jun-27-16 06:08PM  Carl Icahn Says Allergan Is Undervalued, Takes a Large Position
02:05PM  Which Sector of the S&P 500 Index Could Gain in a Flat Market?
Jun-26-16 07:21AM  The 5 Best Healthcare ETFs at Motley Fool
Jun-24-16 04:39PM  Brexit may make health care stocks a good defensive play at MarketWatch
10:38AM  How Healthcare ETFs Could Really Get it Together
09:05AM  Whats the Main Regulatory Risk of the Envision-Amsurg Deal?
Jun-23-16 09:07AM  Could the Envision-Amsurg Deal Get Competitive?
08:23AM  Studies Show Regular Exercise Cannot Counteract Harm Of Sitting All Day At Work
Jun-22-16 11:38AM  Pharma stocks are soaring for the first time in weeks because something didn't happen
09:06AM  What Are the Conditions for the Amsurg-Envision Merger?
Jun-21-16 09:07AM  Whats the Rationale for the Amsurg-Envision Merger?
06:00AM  Health care spending to shift in 2017: PwC
Jun-15-16 11:30AM  Analyzing XLV: It Managed to Stay above $70
Jun-14-16 12:36PM  Monday links: all the risks
Jun-13-16 12:24PM  Centene to Raise $500 Million through Senior Notes
Jun-10-16 03:15PM  Bond yields tumble as traders run to safety
07:30AM  Industrials Flirting with All-Time Highs
Jun-09-16 11:24AM  Valeant Pharmaceuticals: Equity Investors Heartened By Debt Rating Decision at Barrons.com
09:07AM  What Caused Alexion Pharmaceuticals Fall?
Jun-08-16 02:59PM  Why Biogens Stock Price Has Fallen
Jun-07-16 06:08PM  Health ETFs Wilt But Broad U.S. Stock Market Continues To Rally
02:03PM  Biotech Smacked Despite Broad U.S. Stock Rally at Barrons.com
Jun-06-16 03:34PM  Humana Rose on Aetnas $13 Billion Bond Sale
Jun-05-16 01:46PM  The Utilities Sector Gets A Lot More Volatile In The Summer
Jun-02-16 02:18PM  This Chart May Hold Key To Stock Rallys Fate
11:09AM  XLVs Holdings: How Are the Moving Averages Trending?
10:51AM  11 Health Care ETFs for a Heart-Healthy Portfolio
Jun-01-16 01:25PM  Vertex Receives FDA Nod for Priority Review of Orkambi
01:25PM  XLV Broke the $70 Jinx: Its Working to Reach a 3-Month High
10:08AM  How to Invest in US Large-Cap Equity Mutual Funds Going Forward
10:00AM  A Healthy Assessment of Healthcare ETFs
09:07AM  The Healthcare & Biotechnology Index Surprised Markets in April
08:57AM  Your first trade for Wednesday, June 1 at CNBC
May-31-16 04:44PM  Do US GICS Sector Flows Suggest Caution Right Now?
May-27-16 04:16PM  Whats Allergans Growth Strategy?
04:16PM  How Do Allergans Valuations Compare to Its Peers?
12:34PM  Weak global growth will mean market stagnation until the end of 2017: portfolio manager
11:07AM  Inside Bristol-Myers Squibbs Virology Segment
06:00AM  Explaining CRISPR
May-26-16 09:08AM  What Made McKesson the Top Gainer among Biotech Large-Caps?
07:09AM  'Artificial' rates keeps investors in equities: Jim Pauls...
05:30AM  Health Care ETFs Outpacing Market
May-24-16 06:27PM  Richard Bernstein: Corporate Profit Cycle May Be Turning
03:56PM  SPDR Indices Rally as New Homes Sales Hit an 8-Year High
08:15AM  Healthcare ETFs Could Be Second Half Rebound Ideas
08:10AM  Manage Micro-Caps With These ETFs
May-23-16 05:07PM  14 Hedged Bond ETFs to Diminish Rising Rate Risks
04:10PM  The Social Media Index: Todays Market Sentiment Indicator
03:24PM  Taiwan ETF Bounces as New President Provides Clarity
02:47PM  GREK: Greece ETF Surges Thanks to Debt Relief
02:02PM  Bayers Monsanto Bid Lifts Agribusiness ETFs
10:58AM  Plucky Preferred ETFs for Portfolio Income
10:30AM  Signs Keep Pointing to Dollar ETF Upside
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.